COUGH INDUCED BY REMIFENTANIL TREATMENT WITH PROPOFOL DURING TARGET-CONTROLLED INFUSION ANESTHESIA

Main Article Content

Dr. Akkina Sriram
Dr. Navakanth

Keywords

Remifentanil-induced cough, Propofol, Target-controlled infusion, Anaesthetic induction, Airway reflex suppression

Abstract

Background: Remifentanil is commonly used in the anaesthetic induction process but is commonly linked with the occurrence of opioid-related cough, which can be clinically complicated. It is known that Propofol inhibits the airway reflexes, but the interaction of Propofol and remifentanil-induced cough is not fully investigated. Methods: In this randomised trial, patients undergoing general anaesthesia were administered propofol at various target effect-site concentrations (0, 3.0, 4.5 or 6.0 μg/ ml -1) and remifentanil (4.0 ng/ ml -1) as target-controlled rate of IV infusion. Incidences, onset and severity of cough were established, haemodynamic variables and loss of responsiveness. The pharmacodynamic simulations using pharmacokinetics calculated plasma and effect-site remifentanil concentration during the cough onset. Findings Pretreatment with propofol effect-site concentration of 6.0 ug ml -1 had a significant effect on remifentanil-induced cough, but lower concentrations of propofol did not. The dose of remifentanil was similar between groups. Conclusion: Proper propofol pretreatment helps to avoid remifentanil-induced cough during the induction of anaesthesia probably due to a reduction in the disparity between plasma and effect-site concentrations.


 


 

Abstract 0 | PDF Downloads 0

References

Bouvet L, Stoian A, Rimmele T, Allaouchiche B, Chassard D,Boselli E. Optimal remifentanil dosage for providing excellent intubating conditions when co-administered with a single standard dose of propofol. Anaesthesia 2009; 64: 719–26.
2 Bohrer H, Fleischer F, Werning P. Tussive effect of a fentanyl bolus administered through a central venous catheter. Anaesthesia 1990; 45: 18–21.
3 Phua WT, Teh BT, Jong W, Lee TL, Tweed WA. Tussive effect of a fentanyl bolus. Canadian Journal of Anesthesia 1991;38: 330–4.
4 Kim JY, Park KS, Kim JS, Park SY, Kim JW. The effect of lidocaine on remifentanil-induced cough. Anaesthesia 2008;63: 495–8.
5 Agarwal A, Gautam S, Nath SS, Gupta D, Singh U. Comparison of the incidence and severity of cough induced by sufentanil and fentanyl: a prospective, randomised, double-blind study. Anaesthesia 2007; 62: 1230–2.
6 Tweed WA, Dakin D. Explosive coughing after bolus fentanyl injection. Anesthesia and Analgesia 2001; 92: 1442–3.
7 Agarwal A, Azim A, Ambesh S, et al. Salbutamol, beclo-methasone or sodium chromoglycate suppress coughing induced by iv fentanyl. Canadian Journal of Anesthesia 2003;50: 297–300.
8 Lin CS, Sun WZ, Chan WH, Lin CJ, Yeh HM, Mok MS. Intravenous lidocaine and ephedrine, but not propofol, suppress fentanyl-induced cough. Canadian Journal of Anes-thesia 2004; 51: 654–9.
9 Pandey CK, Raza M, Ranjan R, et al. Intravenous lidocaine suppresses fentanyl-induced coughing: a double-blind, prospective, randomized placebo-controlled study. Anesthesia and Analgesia 2004; 99: 1696–8.
10 Cigarini I, Bonnet F, Lorino AM, Harf A, Desmonts JM.Comparison of the effects of fentanyl on respiratory mechanics under propofol or thiopental anaesthesia. Acta Anaesthesiologica Scandinavica 1990; 34: 253–6.
11 Marsh B, White M, Morton N, Kenny GN. Pharmaco-kinetic model driven infusion of propofol in children. British Journal of Anaesthesia 1991; 67: 41–8.
12 Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmaco-dynamics of remifentanil. I. Model development. Anesthesiology 1997; 86: 10–23.
13 Struys MM, De Smet T, Depoorter B, et al. Comparison of plasma compartment versus two methods for effect compartment – controlled target-controlled infusion for propofol. Anesthesiology 2000; 92: 399–406.
14 Lee B, Lee JR, Na S. Targeting smooth emergence: theeffect site concentration of remifentanil for preventing cough during emergence during propofol-remifentanil anaesthesia for thyroid surgery. British Journal of Anaesthesia2009; 102: 775–8.
15 Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD.The effects of increasing plasma concentrations of dex-medetomidine in humans. Anesthesiology 2000; 93: 382–94.
16 Lui PW, Hsing CH, Chu YC. Terbutaline inhalation sup-presses fentanyl-induced coughing. Canadian Journal of Anesthesia 1996; 43: 1216–9.
17 Reitan JA, Stengert KB, Wymore ML, Martucci RW.Central vagal control of fentanyl-induced bradycardia during halothane anesthesia. Anesthesia and Analgesia 1978;57: 31–6.
18 Paintal AS. Mechanism of stimulation of type J pulmonary receptors. Journal of Physiology 1969; 203: 511–32.
19 Lee PC, Cotterill-Jones C, Eccles R. Voluntary control of cough. Pulmonary Pharmacology and Therapeutics 2002; 15:317–20.
20 Orser BA, Bertlik M, Wang LY, MacDonald JF. Inhibitionby propofol (2,6 di-isopropylphenol) of the N-methyl- D -aspartate subtype of glutamate receptor in cultured hippocampal neurones. British Journal of Pharmacology 1995;116: 1761–8.
21 Robertson BS, Satterfield BE, Said SI, Dey RD. N-methyl-D -aspartate receptors are expressed by intrinsic neurons of rat larynx and esophagus. Neuroscience Letters 1998; 244: 77–80.
22 Kamei J, Tanihara H, Igarashi H, Kasuya Y. Effects ofN-methyl- D -aspartate antagonists on the cough reflex. European Journal of Pharmacology 1989; 168: 153–8.
23 Guntz E, Dumont H, Roussel C, et al. Effects of remifentanil on N-methyl- D -aspartate receptor: an electrophysiologic study in rat spinal cord. Anesthesiology2005; 102: 1235–41.
24 Hahnenkamp K, Nollet J, Van Aken HK, et al. Remifentanil directly activates human N-methyl- D -aspartate receptors expressed in Xenopus laevis oocytes. Anesthesiology2004; 100: 1531–7.
25 Haxhiu MA, Deal EC Jr, Norcia MP, van Lunteren E,Cherniack NS. Effect of N-methyl- D-aspartate applied tothe ventral surface of the medulla on the trachea. Journal of Applied Physiololgy 1987; 63: 1268–74.
26 Mertens MJ, Engbers FH, Burm AG, Vuyk J. Predictive performance of computer-controlled infusion of remifenta-nil during propofol ⁄ remifentanil anaesthesia. British Journal of Anaesthesia 2003; 90: 132–41